Apple, Inc.: FDA clearances and approvals

Apple, Inc. has 9 FDA 510(k) clearances (first 2020, latest 2026), plus 3 De Novo decisions, across 7 product codes in 5 review panels. Median 510(k) review time: 135 days. Since 2017 its median was 135 days, against 146 days for all cleared 510(k)s in the same product codes. It is the industry lead sponsor of 6 device clinical trials on ClinicalTrials.gov. It files with the SEC as Apple Inc. (AAPL).

510(k) clearances per year

YearClearancesMedian review days
20201122
2021173
20221165
2023187
20242130
20252180
20261135

Review time against the same product codes

Since 2017, Apple, Inc.'s cleared 510(k)s took a median 135 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 146 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
QDBPhotoplethysmograph Analysis Software For Over-The-Counter Use43
QDAElectrocardiograph Software For Over-The-Counter Use21
SCWDigital Prismatic Correction22
QZWOver-The-Counter Device To Assess Risk Of Sleep Apnea11
SCRAir-Conduction Hearing Aid Software10
SFRHypertension Machine Learning-Based Notification Software11
SHNCalibration Software For Radiology Displays11

Review panels

Most recent Apple, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K253582Medical Imaging Calibration Feature (MICF)SHN2026-04-01135
K250507Hypertension Notification Feature (HTNF)SFR2025-09-11202
K250143Digital Prism Correction Feature (DPCF)SCW2025-06-23157
K242058Digital Prism Correction Feature (DPCF)SCW2024-10-2198
K240929Sleep Apnea Notification Feature (SANF)QZW2024-09-13162
K231173Irregular Rhythm Notification Feature (IRNF)QDB2023-07-2187
K213971Atrial Fibrillation History FeatureQDB2022-06-03165
K212516IRNF AppQDB2021-10-2273
K201525ECG AppQDA2020-10-08122

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN230081De NovoAir-Conduction Hearing Aid Software2024-09-12
DEN180042De NovoPhotoplethysmograph Analysis Software For Over-The-Counter Use2018-09-11
DEN180044De NovoElectrocardiograph Software For Over-The-Counter Use2018-09-11

Recalls

openFDA lists no recalls under a recalling firm named Apple, Inc..

Recalling firms are matched to this company by name only (same normalization as the applicant), so related entities that recall under another name are not counted.

Device clinical trials

Apple, Inc. is the industry lead sponsor of 6 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:

SEC filings

Apple Inc. (AAPL): EDGAR filings, CIK 320193. Matched by exact company name.

Frequently asked questions

How many FDA 510(k) clearances does Apple, Inc. have?

Apple, Inc. has 9 FDA 510(k) clearances (first 2020, latest 2026), plus 3 De Novo decisions, across 7 product codes in 5 review panels.

How long does FDA take to clear Apple, Inc.'s 510(k)s?

The median time from FDA receipt to decision across Apple, Inc.'s cleared 510(k)s is 135 days. Since 2017: 135 days, versus 146 days for all cleared 510(k)s in the same product codes.

What devices does Apple, Inc. make?

Its most frequent FDA product codes are QDB (Photoplethysmograph Analysis Software For Over-The-Counter Use, 4); QDA (Electrocardiograph Software For Over-The-Counter Use, 2); SCW (Digital Prismatic Correction, 2).

Has Apple, Inc. had device recalls?

openFDA lists no recalls under a recalling firm name matching Apple, Inc. Related entities may recall under other names.

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Companies are grouped by FDA applicant name with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice.

All FDA device companies · FDA product code lookup